Coty appoints Markus Strobel as interim CEO starting January

Coty has named Procter & Gamble veteran Markus Strobel as chairman and interim CEO effective Jan. 1, replacing Sue Nabi amid a >50% year-to-date share decline and Paris shares down ~5% on the announcement. Majority owner JAB (≈52%) pushed the leadership shake-up as Coty completes the sale of its remaining 25.8% Wella stake to KKR for $750m and has reduced net debt/EBITDA from >7x in 2020 to below 3x, while launching a strategic review of its consumer-beauty portfolio that could include selling CoverGirl and Rimmel. The company missed Q1 profit estimates, faces mass-market weakness and will lose Gucci fragrance licensing in 2028, although it guided Q2 like-for-like sales toward the top of prior ranges — making restructuring outcomes and activist/strategic moves key near-term valuation catalysts.

Analysis

Market structure: Coty is the clear loser — shares down >50% YTD — while strategic buyers (KKR, prestige players) and stable staples (PG, KO, UL) gain relative defensive flows. Mass-market beauty (CoverGirl, Rimmel) faces secular share loss to indies and prestige, compressing gross margins; fragrances remain higher-margin and are the likeliest value-retention asset. Expect widening equity and credit spreads for COTY (higher CDS/implied bond yields) and elevated equity implied volatility; commodity impact is negligible beyond small fragrance-oil FX exposure.

Risk assessment: Tail risks include an aggressive break-up or asset fire-sale by JAB (accelerating value crystallization), loss of Gucci license in 2028 (material revenue cliff), or covenant stress if FCF deteriorates; each could move equity ±30–60%. Near-term (days–weeks): event-driven volatility around CEO transition and strategic-review updates. Medium-term (3–12 months): brand sales and debt paydown reshape leverage; long-term (2028+) license expiries determine structural revenue trajectory.

Trade implications: Tactical direct short of COTY equity (6–8% portfolio notional) with a 30–50% downside target and hard stop at +20% rallies; hedge with long PG (2–3% position) to offset consumer cyclicality. Consider buying COTY Sep 2026 25% OTM put spreads to cap premium (~cost-defined) and pair trade short COTY / long PG or UL for 1:1 beta neutrality. Rotate 3–5% from mass-market beauty exposures into prestige/fragrance or staples (KO, PG) given lower secular risk.

Contrarian angles: The market may be overdiscounting Coty’s recovery optionality from asset sales — a single divestiture >$750m (Wella-sized) pushing net debt/EBITDA below ~1.5x could re-rate equity 30–60%. Conversely, forced sales at distressed multiples are possible if retail destocking persists. Key mispricing to watch: implied volatility spike vs. fundamental upside from disciplined M&A proceeds and license renegotiations.

Key Decisions for Investors

• Establish a short position in COTY equal to 6–8% of a dedicated event-driven sleeve (use stock or borrow), target nominal downside 30–50% over 3–12 months; set stop-loss if position rises +20% from entry.
• Buy COTY Sep 2026 25% OTM put spread (long put, short further OTM put) sized to cover short stock exposure; this caps cost while preserving asymmetric downside if the strategic review fails.
• Initiate a 1:1 pair trade: short COTY / long PG (Procter & Gamble) sized 2–3% of portfolio to neutralize consumer cyclicality while capturing Coty-specific downside over 3–9 months.
• Allocate 2–3% overweight to KKR (KKR) for M&A/asset-value exposure and 2–3% to KO or UL as defensive rotation away from mass-market beauty; trim mass-beauty ETF/retail exposure by 3–5%.
• Set automated alerts and act triggers: if Coty announces brand sale proceeds >$750m or net debt/EBITDA falls below 2.0x, reduce/cover 50% of short within 7 trading days; if JAB stake changes materially (±5% within 30 days) exit position.